Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Taproot Health
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Celgene
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center